| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 45.362 | 41.726 | 36.083 | 35.190 | - | - | - | - | - |
| Total Income - EUR | - | 46.858 | 41.726 | 36.083 | 35.198 | - | - | - | - | - |
| Total Expenses - EUR | - | 36.950 | 41.963 | 47.502 | 43.754 | - | - | - | - | - |
| Gross Profit/Loss - EUR | - | 9.907 | -238 | -11.419 | -8.556 | - | - | - | - | - |
| Net Profit/Loss - EUR | - | 9.591 | -655 | -11.780 | -9.112 | - | - | - | - | - |
| Employees | - | 3 | 3 | 0 | 1 | - | - | - | - | - |
Check the financial reports for the company - Realloy Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 780 | 6.434 | 3.655 | 1.673 | - | - | - | - | - |
| Current Assets | - | 38.957 | 31.615 | 27.572 | 40.540 | - | - | - | - | - |
| Inventories | - | 13.195 | 17.161 | 18.739 | 13.133 | - | - | - | - | - |
| Receivables | - | 8.058 | 13.725 | 6.131 | 11.208 | - | - | - | - | - |
| Cash | - | 17.704 | 729 | 0 | 16.199 | - | - | - | - | - |
| Shareholders Funds | - | 34.705 | 33.472 | 21.153 | 12.283 | - | - | - | - | - |
| Social Capital | - | 45 | 44 | 43 | 42 | - | - | - | - | - |
| Debts | - | 5.032 | 4.577 | 10.073 | 29.930 | - | - | - | - | - |
| Income in Advance | - | 0 | 0 | 0 | 0 | - | - | - | - | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4646 - 4646" | |||||||||
| CAEN Financial Year |
4646
|
|||||||||
Comments - Realloy Med S.r.l.